(Q42781499)

English

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous co

scientific article published on December 2010

Statements

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous co (English)
1035-41, 1041.e1

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit